Dubai, March 24 -- New research in the United States has found that using a blood thinner medication could improve survival rates for some cancer patients by reducing the risk of blood clots. Blood clots are the second leading cause of death for cancer patients after cancer itself, and one in five will get a blood clot at some point during their illness.
Cleveland Clinic research has found that the blood thinner rivaroxaban significantly reduces venous thromboembolism (VTE) - a blood clot in the venous system - and VTE-related death for outpatient, high-risk cancer patients while they are taking the oral anticoagulant.The study results were published in the New England Journal of Medicine. Alok Khorana, M.D., a Cleveland Clinic medical onc...